Aptiom

Chemical Nameeslicarbazepine acetate
Dosage FormTablet (oral; 200mg, 400mg, 600mg, and 800mg)
Drug ClassAnticonvulsants
SystemNervous
CompanySunovion Pharmaceuticals Inc.
Approval Year2013

Indication

  • Indicated as an adjunct for the treatment of partial-onset seizures.
Last updated on 4/27/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aptiom (eslicarbazepine acetate) Prescribing Information2013Sunovion Pharmaceuticals Inc., Marlborough, MA